As per the Brain and Behavior Research Foundation, it combines two compounds called xanomeline and trospium chloride. This is ...

Besides, slower dose titration in an acute schizophrenic episode may lead to attenuated efficacy. Therefore, the convenient dosage regimen and rapid initiation scheme of quetiapine extended ...

MIAMI LAKES, Fla.--(BUSINESS WIRE)--Segal Trials, a privately held clinical research network specializing in acute schizophrenia and other psychiatric disorders, has released enrollment ...

A phase 2 randomized, double blind, placebo-controlled, multi-center safety and efficacy trial of brilaroxazine in acute schizophrenia patients—patients who are experiencing severe symptoms ...

This symptomatic overlap may make it difficult to distinguish patients presenting with a cocaine-induced psychosis from those patients experiencing an acute schizophrenic episode, or to determine ...

Cognitive issues are core symptoms of schizophrenia. More than 80 percent of people with schizophrenia have cognitive symptoms of some kind. They’re one of the main obstacles to managing ...

The failure of Cerevel's emraclidine in schizophrenia will cost AbbVie an impairment charge of about $3.5 billion, the pharma said in a Jan. 10 filing with the Securities and Exchange Commission.

“The efficacy, safety, and tolerability data observed in this study reinforce the potential of LB-102 to provide a first-in-class benzamide option for patients in the U.S. with acute ...

Patient enrollment advancing in SERENITY At-Home Phase 3 trial of BXCL501 for acute treatment of agitation associated with bipolar disorders or ...

Interestingly, the first English language report on the use of antipsychotic agents in schizophrenia also showed that these drugs have efficacy in the treatment of acute mania, which clinicians ...

The study, titled ‘The Impact of Xanomeline and Trospium Chloride on Cognitive Impairment in Acute Schizophrenia,’ revealed improvement in patients with pre-specified cognitive impairments after ...